Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.

Klinger JR, Pereira M, Del Tatto M, Brodsky AS, Wu KQ, Dooner MS, Borgovan T, Wen S, Goldberg LR, Aliotta JM, Ventetuolo CE, Quesenberry PJ, Liang OD.

Am J Respir Cell Mol Biol. 2019 Nov 13. doi: 10.1165/rcmb.2019-0154OC. [Epub ahead of print]

PMID:
31721618
2.

Biodistribution of Mesenchymal Stem Cell-Derived Extracellular Vesicles in a Radiation Injury Bone Marrow Murine Model.

Wen S, Dooner M, Papa E, Del Tatto M, Pereira M, Borgovan T, Cheng Y, Goldberg L, Liang O, Camussi G, Quesenberry P.

Int J Mol Sci. 2019 Nov 2;20(21). pii: E5468. doi: 10.3390/ijms20215468.

3.

Daily rhythms influence the ability of lung-derived extracellular vesicles to modulate bone marrow cell phenotype.

Dooner MS, Stewart C, Deng Y, Papa E, Pereira M, Del Tatto M, Johnson S, Wen S, Amaral A, Aliotta J, Quesenberry PJ, Goldberg LR.

PLoS One. 2018 Nov 26;13(11):e0207444. doi: 10.1371/journal.pone.0207444. eCollection 2018.

4.

Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.

Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Cheng Y, Goldberg L, Ventetuolo CE, Liang O, Klinger JR, Quesenberry PJ.

Stem Cells Transl Med. 2017 Jul;6(7):1595-1606. doi: 10.1002/sctm.16-0386. Epub 2017 May 5.

5.

Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.

Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Goldberg LR, Baird GL, Ventetuolo CE, Quesenberry PJ, Klinger JR.

Cardiovasc Res. 2016 Jun 1;110(3):319-30. doi: 10.1093/cvr/cvw054. Epub 2016 Mar 14.

6.

Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells.

Mulvey HE, Chang A, Adler J, Del Tatto M, Perez K, Quesenberry PJ, Chatterjee D.

BMC Cancer. 2015 Aug 1;15:571. doi: 10.1186/s12885-015-1568-3.

7.

Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure.

Panagopoulos K, Cross-Knorr S, Dillard C, Pantazatos D, Del Tatto M, Mills D, Goldstein L, Renzulli J, Quesenberry P, Chatterjee D.

Mol Cancer. 2013 Oct 8;12(1):118. doi: 10.1186/1476-4598-12-118.

8.

A new stem cell biology: the continuum and microvesicles.

Quesenberry PJ, Dooner MS, Goldberg LR, Aliotta JM, Pereira M, Amaral A, Del Tatto MM, Hixson DC, Ramratnam B.

Trans Am Clin Climatol Assoc. 2012;123:152-66; discussion 166.

9.

Marrow cell genetic phenotype change induced by human lung cancer cells.

Del Tatto M, Ng T, Aliotta JM, Colvin GA, Dooner MS, Berz D, Dooner GJ, Papa EF, Hixson DC, Ramratnam B, Aswad BI, Sears EH, Reagan J, Quesenberry PJ.

Exp Hematol. 2011 Nov;39(11):1072-80. doi: 10.1016/j.exphem.2011.08.008. Epub 2011 Aug 22.

10.

Microvesicle induction of prostate specific gene expression in normal human bone marrow cells.

Renzulli JF 2nd, Del Tatto M, Dooner G, Aliotta J, Goldstein L, Dooner M, Colvin G, Chatterjee D, Quesenberry P.

J Urol. 2010 Nov;184(5):2165-71. doi: 10.1016/j.juro.2010.06.119. Epub 2010 Sep 18.

11.

Expression of cell cycle-related genes with cytokine-induced cell cycle progression of primitive hematopoietic stem cells.

Quesenberry PJ, Dooner GJ, Tatto MD, Colvin GA, Johnson K, Dooner MS.

Stem Cells Dev. 2010 Apr;19(4):453-60. doi: 10.1089/scd.2009.0283.

12.

Bioartificial muscles in gene therapy.

Powell C, Shansky J, Del Tatto M, Vandenburgh HH.

Methods Mol Med. 2002;69:219-31. No abstract available.

PMID:
11987780

Supplemental Content

Loading ...
Support Center